학술논문
Characterization of folate receptor alpha (FRα) expression in archival tumor and biopsy samples in a phase I study of mirvetuximab soravtansine, a FRα-targeting antibody-drug conjugate (ADC), in relapsed epithelial ovarian cancer patients
Document Type
Abstract
Author
Source
In Gynecologic Oncology June 2017 145 Supplement 1:34-34
Subject
Language
ISSN
0090-8258